Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

1,124.17 +17.09 (+1.54%)
Streaming Delayed Price Updated: 9:46 AM EDT, Jun 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Earnings To Watch: Viatris (VTRS) Reports Q1 Results Tomorrow
Medication company Viatris (NASDAQ:VTRS) will be announcing earnings results this Thursday before the bell. Here’s what investors should know. Viatris beat a... 
Via StockStory
Topics Artificial Intelligence
News headline image
Schrödinger (SDGR) Q1 2026 Earnings Transcript ↗
Schrödinger (SDGR) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Eli Lilly Advances As Inflammatory Bowel Disease Drug Reinforces Long-Term Confidence ↗
Eli Lilly shares rise as Omvoh shows 4-year disease clearance in ulcerative colitis, with consistent safety and strong Crohn's data. 
Via Benzinga
News headline image
3 Quality Compounders to Own for Decades
Quality compounders are well-oiled machines. Their competitive advantages allow them to make profits consistently and reinvest them into projects that genera... 
Via StockStory
News headline image
Elanco (ELAN) Q1 Earnings: What To Expect
Animal health company Elanco (NYSE:ELAN) will be reporting results this Wednesday before the bell. Here’s what investors should know. Elanco beat analysts’ r... 
Via StockStory
Topics Artificial Intelligence
News headline image
Royalty Pharma (RPRX) Reports Q1: Everything You Need To Know Ahead Of Earnings
Healthcare royalties company Royalty Pharma (NASDAQ:RPRX) will be reporting earnings this Wednesday before market hours. Here’s what investors should know. R... 
Via StockStory
Topics Artificial Intelligence
News headline image
3 Reasons It's Not Too Late to Buy Eli Lilly Stock ↗
The company still has a strong lead in its core therapeutic area. 
Via The Motley Fool
News headline image
Is Eli Lilly Stock Heading for $1,000? ↗
Eli Lilly's valuation looks far more attractive now than it did even a year ago. 
Via The Motley Fool
News headline image
3 Absurdly Cheap Growth Stocks to Buy in May 2026 ↗
These stocks have been struggling over the past year, but their growth days are far from over. 
Via The Motley Fool
News headline image
Here's Exactly Why Wall Street Thinks Viking Therapeutics Stock Could Soar 207% Over the Next 12 Months ↗
The Street is bullish on this biotech's prospects, but is the sentiment justified? 
Via The Motley Fool
News headline image
The Most Surprising Thing About Eli Lilly's Impressive Revenue Growth: Just How Much More Potential There Is ↗
Eli Lilly is coming off an impressive first-quarter performance, with sales soaring by 56%. 
Via The Motley Fool
News headline image
Eli Lilly Topples After Weight-Loss Patient Reports A Surprise Side Effect ↗
Eli Lilly stock toppled Monday after a patient taking its new weight-loss pill, Foundayo, experienced liver failure. 
Via Investor's Business Daily
Discover the top S&P500 movers in Monday's pre-market session. ↗
Via Chartmill
News headline image
Eli Lilly Just Announced Fantastic News for Shareholders ↗
Lilly's weight loss drugs have been delivering blockbuster revenue. 
Via The Motley Fool
Topics Earnings
News headline image
Ocular Therapeutix (OCUL) To Report Earnings Tomorrow: Here Is What To Expect
Ophthalmology biopharmaceutical company Ocular Therapeutix (NASDAQ:OCUL) will be announcing earnings results this Tuesday before the bell. Here’s what to loo... 
Via StockStory
News headline image
Pfizer Earnings: What To Look For From PFE
Global pharmaceutical company Pfizer (NYSE:PFE) will be reporting results this Tuesday before the bell. Here’s what investors should know. Pfizer beat analys... 
Via StockStory
News headline image
Jazz Pharmaceuticals (JAZZ) Q1 Earnings Report Preview: What To Look For
Biopharma company Jazz Pharmaceuticals (NASDAQ:JAZZ) will be reporting results this Tuesday after market hours. Here’s what you need to know. Jazz Pharmaceut... 
Via StockStory
Topics Artificial Intelligence
News headline image
Supernus Pharmaceuticals Earnings: What To Look For From SUPN
Specialty pharmaceutical company Supernus Pharmaceuticals (NASDAQ:SUPN) will be announcing earnings results this Tuesday after the bell. Here’s what to look ... 
Via StockStory
Topics Artificial Intelligence
News headline image
Why Eli Lilly Stock Jumped This Week ↗
A new weight loss pill is expanding the pharmaceutical leader's already massive market opportunity. 
Via The Motley Fool
News headline image
Pfizer Stock: Still Priced Like It's Dead Money ↗
Shares of Pfizer are down 50% from their 2021 high, and the yield is an alluring 6.4%. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Dear Veeva Systems Stock Fans, Mark Your Calendar for May 7
Veeva Systems stock pops following S&P 500 inclusion announcement. 
Via Barchart.com
Topics Earnings Stocks
News headline image
Deal Dispatch: Sirius XM Mulls Purchase Of iHeartMedia, Uber Buys FlyTaxi, Wren Kitchens Bankruptcy ↗
Major M&A deals this week include: Eli Lilly buys Profluent for $2.2 billion, Lazard buys Campbell Lutyens, FreshRealm bankruptcy. 
Via Benzinga
News headline image
Lilly's Double-Beat Widens the GLP-1 Gap—And a New Pill Could Make It Permanent ↗
Via MarketBeat
News headline image
There's Another Twist In The Obesity Pills Showdown — And This One Actually Helps Lilly ↗
The prescription data collected for Eli Lilly's new weight-loss pill, Foundayo, is flawed, analysts said Friday. 
Via Investor's Business Daily
News headline image
Why Eli Lilly (LLY) Stock Is Trading Up Today
What Happened? Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 4.3% in the morning session after the stock continued to rally as the comp... 
Via StockStory
News headline image
Viking Therapeutics Faces Timeline Risk—But Upside Could Be Huge ↗
Via MarketBeat
News headline image
Eli Lilly Stock Popped on Earnings. America Can’t Get Enough of Its GLP-1s.
Eli Lilly stock jumps on strong Q1 performance numbers, with its GLP-1s leading the chart. 
Via Barchart.com
News headline image
Eli Lilly Capitalizes On Consumers' 'Love Affair' With Weight Loss Drugs: Gary Black Says Valuation 'Still Looks Compelling' ↗
Gary Black calls Eli Lilly's valuation 'compelling' as Q1 earnings soar, driven by the consumer 'love affair' with GLP-1 weight loss drugs. 
Via Benzinga
News headline image
LLY Q1 Deep Dive: Obesity Franchise Expansion and Pipeline Investment Drive Outperformance
Global pharmaceutical company Eli Lilly (NYSE:LLY) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 55.5% year on year to $19... 
Via StockStory
News headline image
Here's How Much $1000 Invested In Eli Lilly 15 Years Ago Would Be Worth Today ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.